Effect of Topical Aqueous Suppressants on Intraocular Gas Duration Following Pars Plana Vitrectomy

• Status: Completed
• Trial end date: 2013-06-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to see if glaucoma eye drops (dorzolamide-timolol) have any effect on the duration of an intraocular gas bubble following pars plana vitrectomy.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Mid Atlantic Retina
• Treatments: Dorzolamide; Ophthalmic Solutions; Timolol

Criteria

Inclusion Criteria:

• Patients scheduled for pars plana vitrectomy with intraocular gas tamponade with sulfur hexafluoride (e.g., retinal detachment, macular hole, other condition at the discretion of the investigator).

• Ability to provide written informed consent and comply with study assessments for the full duration of the study.

Exclusion Criteria:

• Prior trabeculectomy or tube shunt surgery.

• Current use of topical aqueous suppressants or other glaucoma medications.

• Aphakia or presence of anterior chamber intraocular lens implant.

• Known allergy or contraindication to sulfa or beta-blocker use (e.g., asthma, chronic obstructive pulmonary disease, bradycardia).